Gout and Hyperuricemia: Some New Thoughts About an Old Disease
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, March 18, 2010
First Floor Lecture Hall, Forchheimer/Einstein
Cherkasky Auditorium, Moses/Montefiore
Michael H. Pillinger, MD
Associate Professor of Medicine and Pharmacology, NYU School of Medicine and NYU Hospital for Joint Diseases
Section Chief of Rheumatology, New York Harbor VA Health Care System, New York Campus
Dr. Michael Pillinger's research has focused on the biology of arthritis and inflammation, including the roles of neutrophils and synovial cells in rheumatoid arthritis, and the role of prostaglandins in signal transduction in rheumatoid arthritis, gout and osteoarthritis.
A clinical and research rheumatologist with a strong interest in medical education, Dr. Pillinger has served as the NYU Rheumatology Fellowship Director since 2001. He has served in various educational and administrative capacities for the American College of Rheumatology, the American College of Physicians, and the Arthritis Foundation NY Chapter, including serving as the Basic Science Chair for the American College of Rheumatology Annual Meeting.
Dr. Pillinger served as the rheumatology editor of the Year Book of Medicine from 2002 to 2006, and has served on the editorial boards of Inflammation and FASEB Journal.
Dr. Pillinger is the recipient of multiple awards, including a Clinician Scholar Educator Award from the American College of Rheumatology, and has published more than 90 original manuscripts, reviews and book chapters in the field of arthritis research.
Dr. Pillinger received his bachelor's degree in Biochemistry from Harvard College and his M.D. degree from NYU School of Medicine. He then completed his internal medicine residency at Albert Einstein College of Medicine/Jacobi Hospital before returning to NYU for a rheumatology fellowship, where he served as Chief Rheumatology Fellow from 1992-93.
This grand rounds is hosted by the Division of Rheumatology.
After attending this activity, participants will be able to:
- Discuss the role, and potential benefits, of uric acid in human evolution
- Utilize knowledge about diet and uric acid to reduce patients’ risk for gout and hyperuricemia
- Recognize the benefits/limitations of both traditional gout drugs, and new gout drugs available or about to be so, and use knowledge of those benefits/limitations to optimize gout management
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.